Recent guidelines emphasize that HPV vaccination remains beneficial well into adulthood under specific conditions. While the optimal window remains adolescence (ages 11–12), unvaccinated women up to age 26 should receive the vaccine regardless of HPV exposure, sexual activity, or orientation. For women aged 27–45, shared clinical decision-making is now advised based on their individual risk profile and potential benefit. These recommendations emphasize expanding HPV vaccine coverage across a broader range of age groups.
Test your knowledge on the latest HPV vaccination recommendations and see if you’re up to date on revaccination guidelines! Reference : The American College of Obstetricians and Gynecologists ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no explicit or implied warranties about…
